2017 Astellas Transparency Disclosure Report
Astellas is a member company of the European Federation of Pharmaceutical Industries and Associations (“EFPIA”) and adheres to the EFPIA Disclosure Code 2014 (the “EFPIA Disclosure Code”).
The EFPIA Disclosure Code requires all member companies to document and disclose certain Transfers of Value they make, directly or indirectly, to or for the benefit of, Healthcare Professionals (“HCPs”) or Healthcare Organisations (“HCOs”) (“Disclosures”).
The EFPIA Disclosure Code is implemented in Spain by the Spanish Code Of Good Practice of Pharmaceutical Industry. Astellas discloses all Transfers of Value to HCPs and HCOs in accordance with its commitment to the EFPIA Disclosure Code and the applicable Spanish national code.
“The publication of these data meets the transparency requirements of the Code of Practice for the Pharmaceutical Industry”
“The publication of information is not derived a general power to those who access the site to carry out an additional processing of the HCP´s data, such as its junction with the information published on websites of other partner laboratories.”
“The laboratory has adopted security levels to prevent indexing information through search engines”
- > 2017 DISCLOSURE REPORT ON TRANSFERS OF VALUE FROM PHARMACEUTICAL COMPANIES TO HEALTHCARE PROFESSIONALS AND HEALTHCARE ORGANIZATIONS